MarketInOut Stock Screener Log In | Sign Up

Molbio Diagnostics Ltd

BSE • Healthcare • Medical Devices • Quote as of 10/27/2026 15:56
Molbio Diagnostics Ltd stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeBSE
Market Capitalization146,885 mln
Float8.86 mln

EPS

14.46
Stretched

P / E

87.57
Speculative

1-Year Forecast

1,650.00
Strong upside

Relative Strength

14 / 100
Significantly lagging

Debt / Equity

0.34
Low leverage

Business Description

Molbio Diagnostics Limited is an India-based medical technology company founded in 2000, specializing in tools that allow healthcare providers to quickly test for a wide range of infectious and chronic diseases at the point of care. The company's product lineup includes portable testing machines, disposable test kits for conditions such as dengue, malaria, and COVID-19, as well as its flagship Truenat platform, which uses real-time molecular testing to support treatment decisions for diseases including tuberculosis, HIV, hepatitis, and cervical cancer. Molbio also produces chip-based diagnostic devices, reagents, and X-ray equipment, serving healthcare facilities that need accurate and fast results outside of traditional laboratory settings.

Key Fundamentals

EPS14.46
P/E87.57
RPS156
EBITDA, mln4,348
EV / EBITDA33.31
Revenue, mln17,544
EV / Revenue8.26

Quote Details

Last 1,266.30
Change -9.05 (-0.71%)
Open 1,260.40
Volume 69,606
Turnover 88,142,080
Average Volume 331,075

Financial Ratios

Price / Book12.29
Debt / Equity0.34

Financial Strength

1-Year Target Price1,650.00

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -12.12% 8 / 100   
1 Month 1.87% 84 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog